Founder of Blueprint. I help companies stop sending emails nobody wants to read.
The problem with outbound isn't the message. It's the list. When you know WHO to target and WHY they need you right now, the message writes itself.
I built this system using government databases, public records, and 25 million job posts to find pain signals most companies miss. Predictable Revenue is dead. Data-driven intelligence is what works now.
Your GTM team is buying lists from ZoomInfo, adding "personalization" like mentioning a LinkedIn post, then blasting generic messages about features. Here's what it actually looks like:
The Typical Andwis Group SDR Email:
Why this fails: The prospect is an expert. They've seen this template 1,000 times. There's zero indication you understand their specific situation. Delete.
Blueprint flips the approach. Instead of interrupting prospects with pitches, you deliver insights so valuable they'd pay consulting fees to receive them.
Stop: "I see you're hiring compliance people" (job postings - everyone sees this)
Start: "Your trust's CQC safety rating declined from Good to Requires Improvement in the September inspection, with 2 RIDDOR incidents reported in October" (government database with dates and specific ratings)
PQS (Pain-Qualified Segment): Reflect their exact situation with such specificity they think "how did you know?" Use government data with dates, record numbers, facility addresses.
PVP (Permissionless Value Proposition): Deliver immediate value they can use today - analysis already done, deadlines already pulled, patterns already identified - whether they buy or not.
These messages demonstrate precise understanding of prospects' situations or deliver immediate value. Ordered by quality score—highest impact plays first.
When pharmaceutical manufacturers have GMP compliance variance across facilities, show them exactly which equipment needs protocol updates by comparing their successful site's SOPs to their deficient site's gaps.
You're providing an immediately implementable solution using their own proven protocols. The recipient doesn't need to research vendors or best practices—they already have the answer internally, you're just surfacing it. This demonstrates deep understanding of GMP compliance while making their remediation path obvious.
This play assumes access to FDA 483 observation details and ability to compare validation protocols between facilities. Could require internal document access or interviews with facility managers.
Combined with public MHRA inspection data, this synthesis is unique to deep pharmaceutical compliance expertise.Proactively alert NHS trusts to upcoming lift certification expirations with specific equipment IDs, expiration dates, and the exact procurement timeline needed to avoid compliance gaps and service disruptions.
Certification expirations are high-stakes compliance events that can shut down building access. By surfacing exact dates and procurement deadlines before the recipient realizes they're approaching, you demonstrate proactive partnership and prevent emergency situations. The specificity (equipment IDs, inspector contacts) makes this immediately actionable.
This play requires maintaining a certification tracking database for NHS trusts, either from past customer relationships or by systematically tracking public LOLER records.
This is proprietary data only you have - competitors cannot replicate this proactive alert system.Alert NHS trusts to upcoming fire alarm system certification expirations with specific dates and vendor lead times, preventing compliance gaps that could force building closures.
Fire safety certification lapses can shut down entire building sections and trigger regulatory action. By alerting facilities managers before they realize expirations are approaching—with vendor contacts already identified—you prevent crises rather than responding to them. This positions you as a strategic partner, not a reactive vendor.
This play requires tracking fire safety certification schedules for NHS trusts, either from internal compliance management or systematic monitoring of regulatory filings.
This is proprietary data only you have - competitors cannot provide this proactive timeline intelligence.Analyze CQC inspection citations and RIDDOR incidents to identify specific maintenance categories where preventive schedules are failing, showing exactly where to fix systematic gaps.
Most facilities managers respond to CQC citations reactively. By clustering citations across maintenance categories and linking them to RIDDOR incidents, you're diagnosing the root cause: systematic preventive maintenance failures. This moves the conversation from "fix this one issue" to "fix the underlying process gap" - exactly what NHS trust leadership needs to prevent future regulatory action.
This play combines public CQC and RIDDOR reports with maintenance schedule analysis and preventive maintenance best practices.
Could be enhanced with your company's preventive maintenance protocols for NHS trusts, demonstrating industry expertise.Alert NHS trusts to upcoming HSE-mandated asbestos re-inspection deadlines with the consequence of missing (automatic building closure) and provide vetted regional surveyor contacts.
The automatic building closure consequence creates genuine urgency. By providing a vetted surveyor contact who understands NHS compliance requirements (evidenced by your regional track record), you remove the procurement friction. This isn't just alerting to a problem—you're providing the solution with proof of quality (8 other NHS trusts).
This play combines public HSE asbestos survey requirements with your company's internal network of vetted surveyors who understand NHS compliance requirements.
The regional NHS track record (8 trusts) demonstrates proven quality and makes this referral immediately credible.Analyze NHS trust RIDDOR incidents and CQC maintenance citations to identify specific buildings generating disproportionate safety issues, enabling targeted capital allocation.
Trust leadership needs to prioritize capital investment across large estates. By clustering incidents and citations at the building level—with construction age as context—you're providing exactly the data needed to justify focused remediation spending. This turns scattered safety issues into a strategic facilities investment decision with clear ROI.
This play combines public RIDDOR reports and CQC inspection findings with building-level analysis and property age data.
Could be enhanced with internal maintenance ticket data to validate incident clustering patterns and strengthen the case for targeted investment.Show pharmaceutical manufacturers exactly which building systems are driving compliance variance between their facilities by categorizing FDA observations and comparing across sites.
Quality directors need to prioritize remediation spending across multiple sites. By mapping observations to specific system categories (HVAC, cleanroom protocols, equipment validation) and showing the variance, you're diagnosing exactly where to focus resources. This transforms vague "improve compliance" directives into actionable system-level remediation priorities.
This play assumes access to MHRA-GMDP database and ability to categorize observations by system type through citation text analysis.
Could be enhanced with internal maintenance records showing vendor correlation to observation patterns.When pharmaceutical facilities have cleanroom protocol observations, provide remediation cost benchmarks and show how protocol transfer from their compliant site could reduce costs by 40%.
Quality directors need to budget for remediation. By providing real cost ranges from comparable remediations and suggesting protocol transfer from their own successful facility (with quantified savings), you're making the remediation decision obvious and cost-effective. The 40% cost reduction through internal protocol transfer is immediately compelling.
This play assumes access to pharmaceutical remediation cost data from public sources or industry relationships, combined with analysis of protocol differences between facilities.
The cost benchmark data is proprietary to compliance specialists with deep pharmaceutical industry experience.When a MAT has a RIDDOR incident at one school, identify if other schools in the trust use the same equipment supplier from the same installation period, preventing future incidents.
MAT leadership is accountable for student safety across all schools. By identifying a supplier-level pattern that extends beyond the incident school—with installation date correlation—you're preventing incidents rather than just responding to them. This transforms one school's problem into trust-wide risk mitigation.
This play combines public RIDDOR incident reports with supplier identification through procurement records or site documentation.
Requires synthesis across multiple trusts to identify supplier patterns - demonstrating deep local authority estate knowledge.When pharmaceutical facilities receive HVAC-related FDA observations, provide remediation timeline benchmarks showing median completion times and failure rates, plus vendor performance comparison.
The 90-day corrective action window is inflexible, and the 23% failure rate creates genuine urgency. By providing vendor performance data based on actual FDA outcomes (not promises), you're de-risking the remediation decision. Quality directors need to know which vendors consistently hit FDA timelines—this delivers that answer with evidence.
This play combines public MHRA-GMDP data with analysis of remediation timelines and vendor performance across comparable facilities.
Assumes ability to track which vendors were associated with successful vs failed remediations through industry relationships or historical project tracking.Show NHS trusts how coordinating lift inspections across multiple buildings with a single vendor in the same week saves 30% vs sequential site-by-site procurement.
Facilities managers often procure services building-by-building without considering multi-site coordination opportunities. By quantifying the 30% cost savings and identifying vendors capable of multi-site coordination, you're reducing both cost and procurement complexity. This positions you as a strategic partner focused on their operational efficiency, not just selling services.
This play requires cost data comparing single-vendor vs multi-vendor lift inspection pricing, and relationships with regional vendors capable of multi-site coordination.
This is proprietary data only you have - competitors cannot quantify the multi-site coordination savings without historical project data.Identify vendor fragmentation across a MAT's estate and correlate vendor performance with Ofsted safety ratings, showing which vendors are associated with compliant vs non-compliant schools.
MAT leadership struggles with vendor management across multiple schools. By mapping vendor patterns and correlating them with Ofsted outcomes, you're diagnosing exactly which vendor relationships are creating risk. The finding that flagged schools share the same vendor while compliant schools use different ones creates an obvious action: vendor consolidation.
This play assumes ability to identify fire system vendors through public procurement records or site visits, then correlate with Ofsted outcomes.
Could be enhanced with internal maintenance schedule data showing how vendor contract terms affect compliance outcomes.Target MATs showing variance in Ofsted safety ratings across their portfolio combined with RIDDOR incidents at underperforming sites, indicating lack of centralized compliance standards and governance gaps.
MAT leadership is accountable for consistent standards across all schools. When Ofsted ratings vary widely (some schools "Good", others "Requires Improvement") and RIDDOR incidents occur at the lower-rated schools, it reveals governance failures. Naming the specific school with the incident and quantifying the portfolio variance creates urgency before upcoming inspections at underperforming schools.
Target pharmaceutical manufacturers where one facility has FDA 483 observations while another facility passed with zero, indicating inconsistent vendor management or maintenance protocols across their portfolio.
Quality directors are accountable for consistent GMP compliance across all facilities. When one site passes FDA inspections while another accumulates observations, it proves the company knows how to achieve compliance—they're just not doing it consistently. The cross-site comparison creates urgency and makes the path forward obvious: standardize what the compliant site does.
Target NHS trusts showing CQC safety rating decline (from 'Good' to 'Requires Improvement') combined with HSE-reportable incidents in the past 12 months, indicating systemic facility management issues requiring urgent remediation before next CQC inspection cycle.
CQC re-inspects declining trusts within 6 months. The combination of declining rating plus recent RIDDOR incidents creates compounding regulatory pressure that facilities managers can't ignore. The 6-month timeline is accurate and creates genuine urgency, while the routing question makes response easy.
Target MATs where a specific school's RIDDOR incident appears in Ofsted safeguarding reviews, and other schools in the trust also show safety concerns, creating risk of trust-level investigation escalation.
Naming the specific school and specific month demonstrates precise research. The trust-level investigation threat is real and terrifying for MAT leadership—Ofsted can escalate from school-level to trust-level scrutiny when patterns emerge. The synthesis of school-level incident and trust-wide risk creates genuine urgency.
Target NHS trusts where RIDDOR incidents occurred in the same month, both related to building systems failures, while the trust already has a CQC safety rating at "Requires Improvement" - creating scrutiny risk in next inspection.
The specific incident count and month demonstrate precision. Linking the RIDDOR incidents to the existing CQC rating decline shows synthesis—this isn't just reporting incidents, it's understanding regulatory consequences. CQC will scrutinize these incidents in the next inspection, creating genuine urgency.
Old way: Spray generic messages at job titles. Hope someone replies.
New way: Use public data to find companies in specific painful situations. Then mirror that situation back to them with evidence.
Why this works: When you lead with "Your trust's CQC safety rating declined from Good to Requires Improvement in the September inspection, with 2 RIDDOR incidents reported in October" instead of "I see you're hiring for compliance roles," you're not another sales email. You're the person who did the homework.
The messages above aren't templates. They're examples of what happens when you combine real data sources with specific situations. Your team can replicate this using the data recipes in each play.
Every play traces back to verifiable public data (or proprietary internal data). Here are the sources used in this playbook:
| Source | Key Fields | Used For |
|---|---|---|
| CQC Inspection Data | provider_name, safety_domain_ratings, inspection_date, regulated_activities | NHS Trusts with declining safety ratings |
| HSE RIDDOR Injury Statistics | establishment_name, incident_type, incident_date, injury_classification | NHS trusts, MATs, universities with recent safety incidents |
| Government Property Estate Dataset | building_construction_date, floor_area, occupying_organisation, location | MOD installations, government offices, university estates |
| Ofsted School Inspection Reports | school_name, safety_inspection_results, safeguarding_assessment, premises_condition | MATs, independent schools with safety concerns |
| NHS Trust Accounts Data | trust_name, capital_expenditure, estate_maintenance_budget, financial_performance | NHS trusts with budget constraints + compliance pressure |
| MHRA-GMDP Manufacturing Facility Database | manufacturer_name, facility_location, gmp_certificate_status, inspection_outcome | Pharmaceutical manufacturers with multi-site compliance variance |
| Internal Data (Proprietary) | certification_expiration_dates, remediation_timelines, vendor_performance, cost_benchmarks | Proactive alerts, cost analysis, vendor recommendations, protocol comparisons |